These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6707382)

  • 1. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.
    Shen EN; Sung RJ; Morady F; Schwartz AB; Scheinman MM; DiCarlo L; Shapiro W
    J Am Coll Cardiol; 1984 May; 3(5):1291-7. PubMed ID: 6707382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
    J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
    J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic and electrophysiologic effects of oral propafenone.
    Prystowsky EN; Heger JJ; Chilson DA; Miles WM; Hubbard J; Zipes DP
    Am J Cardiol; 1984 Nov; 54(9):26D-28D. PubMed ID: 6496366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
    Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
    Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
    Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
    Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M; Steinbeck G; Lüderitz B
    Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical electrophysiology of intravenous indecainide.
    Horowitz LN; Spielman SR; Webb CR; Morganroth J; Greenspan AM
    Am Heart J; 1985 Oct; 110(4):784-8. PubMed ID: 4050649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia.
    Garcia-Civera R; Sanjuan R; Morell S; Ferrero JA; Miralles L; Llavador J; Lopez-Merino V
    Pacing Clin Electrophysiol; 1984 Jul; 7(4):649-55. PubMed ID: 6205364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time.
    Kus T; Dubuc M; Lambert C; Shenasa M
    J Am Coll Cardiol; 1990 Nov; 16(5):1229-37. PubMed ID: 2229772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F; Bracchetti D; Palmieri M; Marchesini B; Ambrosioni E
    Am J Cardiol; 1984 Nov; 54(8):1008-14. PubMed ID: 6496321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA; Allen BJ; Abate D; Henry WL
    Am Heart J; 1985 Oct; 110(4):794-9. PubMed ID: 4050651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy.
    Heger JJ; Hubbard J; Zipes DP; Miles WM; Prystowsky EN
    Am J Cardiol; 1984 Nov; 54(9):40D-44D. PubMed ID: 6496368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and electrophysiologic effects of combined infusion of lidocaine and propafenone in humans.
    Feld GK; Nademanee K; Singh BN; Kirsten E
    J Clin Pharmacol; 1987 Jan; 27(1):52-9. PubMed ID: 3680555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
    Chazov EI; Rosenshtraukh LV; Shugushev KK
    Am Heart J; 1984 Sep; 108(3 Pt 1):483-9. PubMed ID: 6382989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Ludmer PL; McGowan NE; Antman EM; Friedman PL
    J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.